Market Dynamics

Gradual increase in cases in hospitals related to spinal fracture and rapid technological advancement in surgical equipments providing high success ratio are factors expected to drive the growth of global kyphoplasty market. According to the National Osteoporosis Foundation (NOF), in the United States in 2010 more than 10 million adults age 50 years and older had osteoporosis and more than 43 million had low bone mineral density (BMD). In the United States in 2015, as many as 2 million Medicare beneficiaries sustained 2.3 million osteoporotic fractures. Within 12 months of experiencing a new osteoporotic fracture, approximately 15% of patients suffered one or more subsequent fractures and nearly 20% died. Medical equipment manufacturers are investing high for product development their approach towards development of advanced devices that assist healthcare professional in critical spaces during surgery. Players are introducing new innovative products this factor is expected to impact the growth of kyphoplasty market.

In 2020, Medtronic plc a global medical device manufacturing company launched kyphon assist directional cannula for use with its balloon kyphoplasty (BKP) products to treat vertebral compression fractures due to osteoporosis, cancer or benign lesions. This product launch is expected to help the company to enhance the product portfolio and increase the customer base.

In 2020, IZI Medical Products, LLC a global manufacturer of interventional radiology devices launched Osteo-Site Vertebral Balloon for vertebral augmentation. This is expected to help the company to increase its revenue share.

In 2017, VEXIM a medical device company specializing in the minimally invasive treatment of vertebral fractures launched Masterflow Plus, a new product targeted at low energy osteoporotic fractures in Germany. This product launch is expected to help the company to strengthen its position in Germany market and increase the customer base.

Manufacturers are focused on expanding their business in developing countries by establishing the production unit. This is majorly due to developing healthcare standards and easy availability of raw material & low cost labor. Their approach towards strategic partnership with regional players in order to strengthen the distribution channel is factor expected to augment the growth of kyphoplasty market. Factors such as high cost of devices and surgical procedures and stringent government regulation related to product approval are expected to hamper the growth of global kyphoplasty market. In addition, side effects such as cement leakage and post surgical spinal pain are factors expected to challenge the growth of kyphoplasty market. However, technological advancements by major players for development of advanced product and integration of AI in surgical devices for better surgical results are factors expected to create new opportunities for players operating in kyphoplasty market. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue transaction of the target market.

Segment Analysis by Region

North America is expected to account for major revenue share in the global kyphoplasty market due to high patient pool suffering from spinal fracture. In addition, availability of advanced surgical equipments & reimbursement policies by the government and innovative product offering by major players are factors expected to augment the growth of kyphoplasty market.

Increasing merger & acquisition activities by players in order to increase the business presence and customer base is another factor expected to support the growth of kyphoplasty market.

Competitive Landscape      

The global kyphoplasty market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.

Report coverage

Kyphoplasty Market Segment Analysis, 2019

The global kyphoplasty market is segmented into product type, application and end use. The product type segment is bifurcated into balloon kyphoplasty systems, needle kyphoplasty systems, x-ray device kyphoplasty systems. Among the product type the balloon kyphoplasty systems is expected to account for major revenue share in the target market. The application segment is divided into restoring lost vertebral body, correction of the local kyphosis. Among application the restoring lost vertebral body segment is expected to account for significant revenue share in the target market. The players profiled in the report Medical Device Business Services, Inc., Stryker Corporation, BD, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd., G-21 s.r.l., Spinus, Medtronic, Globus Medical, SOMATEX Medical Technologies GmbH, Zimmer Biomet, and Parallax health Sciences, Inc.

Market Segmentation

Market By Product Type

Balloon Kyphoplasty Systems

Needle Kyphoplasty Systems

X-Ray Device Kyphoplasty Systems

Market By Application

Restoring Lost Vertebral Body

Correction of The Local Kyphosis

Market By End Use

Hospitals

Clinics

Ambulatory Surgical Centers

Market By Region

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa